Turnover
≈ €910,000 estimated
The abbreviated format states no turnover.
OCULUX
Lifetime
2 annual accounts with figures on one time axispeak €782,119 (2024)
€597,107▼ 23.7%
-not published
peak €150,000 (2024)
€150,000unchanged
€1.2m▼ 17.4%
peak 7.5 FTE (2025)
7.5 FTE▲ 23.0%
Board2 names since 2023
2 directors and 1 other
Owners2 names in the annual accounts
50%
Documentsfilings and deeds
23-06-202638 days before the deadline
2025abbreviated format
Gross margin from €782,119 to €597,107Staff from 6.1 FTE to 7.5 FTEDebts from €1.5m to €1.2m
Key points
from the 2025 annual accountsDebts
€1.2m 89% of the balance sheet
Financial debts 23%Suppliers 4%Taxes and wages 0%Other 72%
Of this, €949,280 falls due within a year.
Investments
€42,787 0.3 × depreciation
Green is investment, beige is depreciation.
Staff
9 employees on 31-12-2025
In 2025, 61 people joined and 60 left.
Starting capital
€150,000 1,000 shares
Position in the sector
10.8%
Lower solvency than 84% of companies in human health. Sector median 59.4% · 2,807 companies.
Bankruptcy probability
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability within 12 months
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, , since 01-07-2023
Director, since 01-07-2023
- 50%score equity €614,217 (2025) · 2025 annual accounts of
- 50%score equity €153,174 (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0803897002
Incorporation
Appointments: (director) and (director) · Permanent representatives: and · Founder: · published on 17-07-2023 · Gazette deed
First establishment
Witte Torenwal 9, Bree
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| OCULUX Bree | €1.4m | €597,107 | 10.8% | 7.5 |
| O2 CLINIC Antwerp | €0.9m | €563,420 | 1.1% | 8.2 |
| DOKTERSHUIS ANTVERPIA Antwerp | €1.4m | €710,408 | -6.7% | 9.5 |
| MKA HASSELT Hasselt | €2.0m | €499,760 | 0.8% | 7.2 |
| Oogcentrum ZIE Tongeren-Borgloon | €1.0m | €872,402 | 42.5% | 10.3 |
| New Vision Oogkliniek Zuid-Brabant Halle | €1.7m | €501,161 | 1.2% | 3.8 |
| New Vision Oogpraktijk Laakdal | €1.4m | €688,003 | -8.1% | 5.9 |
These companies have the same main activity as OCULUX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €918,000 and €2m, founded between 2020 and 2024.
Official details
Source: KBO- Status
- Active since 12-07-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330Health institutions and services · annual accounts 2025
- Establishment unit
- 2.347.847.0893960 Bree, since 12-07-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 20-02-2026
Annual accounts 2025
- €1.4m▼ 15.9%
- Employeeson 31-12-2025
- 9▲ 12.5%
- Filing
- Filed on 23-06-2026, 38 days before the end of the filing period
Insights on OCULUX
OCULUX has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €150,000.
Its solvency ranks better than 15% of 2,807 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about OCULUX
- What is the company number of OCULUX?
- The company number of OCULUX is 0803.897.002. The VAT number is the same number with BE in front: BE 0803.897.002.
- Where is OCULUX based?
- The registered office is at Witte Torenwal 9, 3960 Bree.Company details
- What does OCULUX do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of OCULUX?
- OCULUX is a private limited company (BV).
- When was OCULUX founded?
- OCULUX was founded on 12-07-2023.
- Is OCULUX still active?
- Yes, OCULUX is an active enterprise in the KBO register.
- How many employees does OCULUX have?
- OCULUX had an average of 7.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does OCULUX fall under?
- In its 2025 annual accounts, OCULUX states joint committee 330 (Health institutions and services).
- What is the turnover of OCULUX?
- The turnover in financial year 2025 is ≈ €910,000. This figure is estimated from the gross margin of €597,107 and 30 comparable companies (NACE 86220). It probably lies between €810,000 and €1.3m.
- Where can I find the annual accounts of OCULUX?
- OCULUX filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of OCULUX due?
- OCULUX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.